Average Co-Inventor Count = 3.77
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rigel Pharmaceuticals, Incorporated (9 from 488 patents)
2. Acumen Pharmaceuticals, Inc. (2 from 8 patents)
11 patents:
1. 9040462 - In vivo production of cyclic peptides for inhibiting protein-protein interaction
2. 9006283 - Methods of modifying amyloid β oligomers using non-peptidic compounds
3. 8962677 - Methods of restoring cognitive ability using non-peptidic compounds
4. 7781182 - Ubiquitin ligase assay
5. 7524642 - Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
6. 7378248 - In vivo production of cyclic peptides for inhibiting protein-protein interaction
7. 7252952 - In vivo production of cyclic peptides for inhibiting protein—protein interaction
8. 7022493 - Ubiquitin conjugation assays
9. 6979551 - Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
10. 6919184 - Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
11. 6737244 - Ubiquitin ligase assay